# 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

> **NCT03541720** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 13 (actual)

## Conditions studied

- Neuroblastoma
- Pheochromocytoma

## Interventions

- **DRUG:** 18F-DA

## Key facts

- **NCT ID:** NCT03541720
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-04-30
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03541720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03541720, "18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT03541720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*